<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Trials.knit</title>

<script src="site_libs/header-attrs-2.28/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/font-awesome-6.4.2/css/all.min.css" rel="stylesheet" />
<link href="site_libs/font-awesome-6.4.2/css/v4-shims.min.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>







<link rel="stylesheet" href="styles.css" type="text/css" />



<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}

.tocify-subheader {
  display: inline;
}
.tocify-subheader .tocify-item {
  font-size: 0.95em;
}

</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Renal Medicine</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Research
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./trials.html">Active Metro North KHS Trials</a>
    </li>
    <li>
      <a href="./Research_MN_output.html">Metro North KHS Research</a>
    </li>
    <li>
      <a href="./fullpubslist.R.html">Full KHS publication list</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    GEN
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./HTN.html">HTN</a>
    </li>
    <li>
      <a href="./CCF.html">CCF</a>
    </li>
    <li>
      <a href="./DKD.html">DKD</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    U&amp;E
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./acidbase.html">H+ &amp; HCO3</a>
    </li>
    <li>
      <a href="./na.html">Na</a>
    </li>
    <li>
      <a href="./k.html">K</a>
    </li>
    <li>
      <a href="./mg.html">MG</a>
    </li>
    <li>
      <a href="./renalbone.html">Ca2+ &amp; PO4</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    GN
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./MCD.html">MCD</a>
    </li>
    <li>
      <a href="./ANCA.html">ANCA</a>
    </li>
    <li>
      <a href="./IGAN.html">IGAN</a>
    </li>
    <li>
      <a href="./MPGN_C3G.html">MPGN &amp; C3G</a>
    </li>
    <li>
      <a href="./LUPUS.html">LUPUS</a>
    </li>
    <li>
      <a href="./FSGS.html">FSGS</a>
    </li>
    <li>
      <a href="./TMA.html">TMA</a>
    </li>
    <li>
      <a href="./GBM.html">GBM</a>
    </li>
    <li>
      <a href="./MN.html">MN</a>
    </li>
    <li>
      <a href="./Amyloid.html">Amyloid</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    CKD
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Checklist</a>
    </li>
    <li>
      <a href="./project1.html">Conservative care</a>
    </li>
    <li>
      <a href="./anaemia.html">Anaemia</a>
    </li>
    <li>
      <a href="./project1.html">Pruritis</a>
    </li>
    <li>
      <a href="./renalbone.html">CKD-MBD</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    TX
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Cheat sheet</a>
    </li>
    <li>
      <a href="./txnotes.html">Misc Notes</a>
    </li>
    <li>
      <a href="./nonkidneytx.html">Non Kidney Tx</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    RRT
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./HD.html">HD</a>
    </li>
    <li>
      <a href="./project1.html">Home HD</a>
    </li>
    <li>
      <a href="./project1.html">HD Access</a>
    </li>
    <li>
      <a href="./project1.html">PD</a>
    </li>
    <li>
      <a href="./project1.html">CVVH</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    DRUGS
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./anticoagulation.html">Anticoagulation</a>
    </li>
    <li>
      <a href="./PJP.html">PJP</a>
    </li>
    <li>
      <a href="./abx.html">Abx</a>
    </li>
    <li>
      <a href="./aboutme.html">HDU</a>
    </li>
    <li>
      <a href="./project1.html">Flozins</a>
    </li>
    <li>
      <a href="./rituxcyc.html">RITUX &amp; CYC</a>
    </li>
    <li>
      <a href="./Chemotherapy.html">Chemo</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    MISC
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./biopsy.html">Biopsy</a>
    </li>
    <li>
      <a href="./path.html">PATH</a>
    </li>
    <li>
      <a href="./preg.html">Pregnancy</a>
    </li>
    <li>
      <a href="./project1.html">PEX</a>
    </li>
    <li>
      <a href="./Lymphoproliferative.html">Lymphoproliferative</a>
    </li>
    <li>
      <a href="./covid19.html">SARS-Cov-2</a>
    </li>
    <li>
      <a href="./Tumour_Lysis.html">Tumour Lysis Syndrome</a>
    </li>
    <li>
      <a href="./Single Kidney.html">Single Kidney</a>
    </li>
    <li>
      <a href="./IGG4.html">IGG4</a>
    </li>
    <li>
      <a href="./Stones.html">Stones</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Resources
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./edu.html">Educational Resources</a>
    </li>
    <li>
      <a href="./patient_resources.html">Patient Resources</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https:eoindosullivan.com">
    <span class="fas fa-home"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">




</div>


<div id="contact-research-nurses-for-screening-enrolment"
class="section level4">
<h4>Contact research nurses for screening &amp; enrolment</h4>
<p><br></p>
</div>
<div id="adpkd" class="section level1">
<h1>ADPKD</h1>
<p><br></p>
<div id="impede" class="section level2">
<h2>IMPEDE</h2>
<p>Metformin vs Placebo for patients with ADPKD</p>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>eGFR &gt;45</li>
<li>Can be on tolvaptan</li>
</ul>
<p><br></p>
</div>
</div>
<div id="hd" class="section level1">
<h1>HD</h1>
<p><br></p>
<div id="acheive" class="section level2">
<h2>ACHEIVE</h2>
<p>Spiro vs Placebo in patients on HD</p>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>on HD or PD &gt;= 3/12</li>
<li>&gt;45 yo</li>
<li>&gt;18 if DM</li>
<li>Exluded if K+ &gt;5.8</li>
</ul>
<p><br></p>
</div>
</div>
<div id="ckd" class="section level1">
<h1>CKD</h1>
<p><br></p>
</div>
<div id="gn---lupus" class="section level1">
<h1>GN - LUPUS</h1>
<p><br></p>
<div id="alxn-1210" class="section level2">
<h2>ALXN 1210</h2>
<p><strong>A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants
With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy
completed (IgAN)</strong></p>
<ul>
<li><strong>Ravulizumab</strong> is a humanized monoclonal antibody
which inhibits complement component 5</li>
<li>Similar to eculizumab but much longer acting</li>
<li>PBS approved for PNH</li>
<li>There is substantial interest in the role of complement pathway in
lupus nephritis</li>
</ul>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>Age between 18 and 75</li>
<li>Body weight &gt;40kg</li>
<li>Must be vaccinated or agree to be vaccinated against Meningococcal
infection, Haemophilus influenza type b and Streptococcus pneumoniae
prior to randomization.</li>
<li>Participants on SGLT-2 inhibitors must be on a stable dose 12 weeks
prior to screening</li>
<li>Kidney biopsy diagnosed class III or class IV LN within 6mths of
screening or during screening</li>
<li>Clinical diagnosis of SLE</li>
<li>Proteinuria with UPCR ≥ 1g/g</li>
</ul>
<p><br></p>
</div>
</div>
<div id="gn---fsgs" class="section level1">
<h1>GN - FSGS</h1>
<p><br></p>
<div id="affinity" class="section level2">
<h2>AFFINITY</h2>
<p>A Phase 2, Open-Label, Basket Study of Atrasentan in Patients with
Proteinuric Glomerular Diseases</p>
<p>The Phase 2 AFFINITY study will assess the efficacy and safety of
atrasentan in patients with proteinuric glomerular diseases at risk of
progressive kidney function loss.</p>
<p>Cohort 2 – FSGS</p>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>Biopsy confirmed FSGS</li>
<li>UPCR&gt;1.5g/g</li>
<li>eGFR ≥ 30mL/min/1.73m2</li>
<li>Receiving RAS inhibitor stable for 12 weeks pre screening</li>
<li>If receiving systemic corticosteriods or calcineurin inhibitors,
dose must be stable for 12 weeks pre screening</li>
<li>BMI &lt; 40 Kg/m2</li>
</ul>
<p><br></p>
</div>
<div id="bi-1434" class="section level2">
<h2>BI 1434</h2>
<p>A multicentre, randomized, double-blind, parallel group, placebo
controlled study to assess safety, tolerability, pharmacokinetics and
pharmacodynamics of BI 764198 administered orally once daily for 12
weeks in patients with focal segmental glomerulosclerosis.</p>
<p>BI 764198 is a potent inhibitor of human TRPC6</p>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>18 – 75 and able to sign Informed Consent</li>
<li>Biopsy Proven FSGS or documented TRPC6 mutation</li>
<li>UPCR ≥ 1000mg/g</li>
<li>Completion of initial corticosteroid therapy (if applicable).</li>
<li>Patients treated with corticosteroids must be on a stable dose for
at least 4 weeks prior to</li>
<li>screening visit with no plan to change the dose until end of trial
treatment.</li>
<li>Pt’s treated with ACE inhibitors, ARBs, finerenone, aldosterone
inhibitors, or SGLT2 inhibitors should be on a stable dose for &gt;4
weeks before screening visit with no plan to change the dose until the
end of trial treatment.</li>
</ul>
<p><br></p>
</div>
</div>
<div id="gn---nephrotic-syn" class="section level1">
<h1>GN - NEPHROTIC SYN</h1>
<p><br></p>
<div id="apaxans" class="section level2">
<h2>APAXANS</h2>
<p>This study will evaluate primarily the pharmacokinetics and safety
and efficacy of apixaban as a preventative for venous thromboembolism in
patients with nephrotic syndrome as compared to warfarin</p>
<p><strong>Inclusion Criteria</strong></p>
<ul>
<li>All adult patients with nephrotic syndrome with serum albumin
&lt;25g/L (<em>for prevention of nephrotic syndrome related thrombotic
disease</em>)</li>
<li>Minimum age: 18 years /Maximum age: No Limit/Gender: both male and
female</li>
</ul>
<p><strong>Exclusion Criteria</strong></p>
<ul>
<li>eGFR of less than 25mL/min /Patients requiring any form of
dialysis</li>
<li>Abnormal liver dysfunction {defined as chronic Liver Disease
(Child-Pugh score of B or C cirrhosis) or biochemical evidence of
significant hepatic derangement (bilirubin 2-3 times the upper limit of
normal, in association with aspartate transaminase (AST) or alkaline
phosphatase (ALP) levels 3 times the upper limit normal).}</li>
<li>Known hereditary or acquired bleeding disorders</li>
<li>Antiphospholipid syndrome</li>
<li>Haemoglobin (Hb) &lt;90g/L/ Platelets &lt;100,000/ul</li>
</ul>
<p><br></p>
</div>
</div>
<div id="gn---anca" class="section level1">
<h1>GN - ANCA</h1>
<p><br></p>
<div id="anca-relapse" class="section level2">
<h2>ANCA Relapse</h2>
<p><strong>Inclusion Criteria</strong></p>
<p>Existing and new patients with confirmed ANCA + ve vasculitis
attending follow-up for ongoing monitoring <br></p>
</div>
</div>
<div id="registries" class="section level1">
<h1>Registries</h1>
<p><strong>Three registries are ongoing.</strong></p>
<ul>
<li>QRBR – Inclusion criteria: patients undergoing renal biopsy</li>
<li>aHUS Registry- Inclusion criteria- Patients diagnosed to have aHUS
(received/receiving Eculizumab)</li>
<li>AUSLUPUS Registry- Inclusion criteria – Patients diagnosed to have
SLE/Lupus Nephritis</li>
</ul>
</div>
<div id="previous-trials-recruited-in-khs" class="section level1">
<h1>Previous Trials recruited in KHS</h1>
<p>Data collected from 2023 onwards</p>
<div id="falcon" class="section level3">
<h3>FALCON</h3>
<p>Bardoxylone vs Placebo for patients with ADPKD</p>
<p><strong>Recruitment stopped Q1 2023</strong></p>
</div>
<div id="affinity-1" class="section level3">
<h3>AFFINITY</h3>
<p>A Phase 2, Open-Label, Basket Study of Atrasentan in Patients with
Proteinuric Glomerular Diseases</p>
<p><strong>Alports population recruitment stopped Q1 2023</strong></p>
</div>
<div id="phosphate" class="section level3">
<h3>PHOSPHATE</h3>
<p>Phosphate targets of &lt;= 1.5 vs 2-2.5 in patients on HD</p>
<p><strong>Recruitment target met Q2 2023</strong></p>
</div>
<div id="align" class="section level3">
<h3>ALIGN</h3>
<p>A Phase 3, Randomized, Double-blind, Placebo-controlled Study of
Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss
of Renal Function</p>
<p><strong>Recruitment finished Q2 2023</strong></p>
</div>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = false;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
